Symbiosis Pharmaceutical Services

Symbiosis Pharmaceutical Services is a world-class fill-finish CDMO based in Stirling, UK, specializing in GMP aseptic manufacturing of injectable biologics and small molecules for clinical trial and commercial supply.

Core Services

• Aseptic GMP Manufacturing – liquid and lyophilised drug products at clinical and commercial scale
• Bulk Lyophilisation – specialized handling and cyclic development
• Drug Product Testing & QC Inspection – analytical testing and quality control
• Labelling and Packaging – secondary packaging and clinical label/pack services
• QP Release – qualified person release for regulatory compliance
• Temperature-Controlled Storage and Shipment – cold chain management
• Product Development – formulation support and process development to transition from pre-clinical to clinical phases

Modality Expertise

Symbiosis has extensive experience across:

• mAbs and Recombinant Therapies – hundreds of delivered projects
• ATMPs/Viral Vector Therapies – clinical and small-scale commercial manufacturing of advanced therapeutics including viral vectors for cell and gene therapies, oncolytic viruses, and critical raw materials such as plasmids
• RNA and Peptide Therapies – challenging manufacturing and handling requirements with specialist knowledge
• Antibody-Drug Conjugates (ADCs) – highly potent materials requiring specialist handling
• Small Molecule – GMP manufacturing across a wide range of applications, including highly potent materials
• Vaccines – clinical batches across traditional attenuated/inactivated products to recombinant, viral vector, and nucleic acid-based vaccine technologies

Regulatory & Quality

Symbiosis' GMP-compliant biologic production facilities are fully licensed by the MHRA. The company emphasizes operational flexibility and regulatory compliance as core strengths, with expert project management offering a single point of contact throughout each project.